Collegium Pharmaceutical, Inc. (COLL) financial statements (2021 and earlier)

Company profile

Business Address 100 TECHNOLOGY CENTER DRIVE
STOUGHTON, MA 02072
State of Incorp. VA
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments17417014711915396
Cash and cash equivalents17417014711915396
Receivables837378102 
Inventory, net of allowances, customer advances and progress billings1610821 
Inventory1610821 
Prepaid expense313111
Deferred costs     0
Other current assets001000
Other undisclosed current assets12111 
Total current assets:27825623813315997
Noncurrent Assets
Operating lease, right-of-use asset89
Property, plant and equipment19129211
Intangible assets, net (including goodwill), including:3363044 2 
Intangible assets, net (excluding goodwill)336     
Other undisclosed intangible assets, net (including goodwill) 3044 2 
Restricted cash and investments3  000
Other noncurrent assets00000 
Total noncurrent assets:3665154231
TOTAL ASSETS:64430629113616298
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities35404314186
Accounts payable10612694
Accrued liabilities253331992
Debt4742 33
Other undisclosed current liabilities157158145175 
Total current liabilities:23920218931268
Noncurrent Liabilities
Long-term debt and lease obligation2181710 14
Long-term debt, excluding current maturities210810 14
Operating lease, liability99
Liabilities, other than long-term debt  1 00
Deferred revenue and credits 00
Other liabilities  1   
Other undisclosed noncurrent liabilities(9)     
Total noncurrent liabilities:2181711 24
Total liabilities:458219200312713
Stockholders' equity
Stockholders' equity attributable to parent, including:186879210413585
Common stock000000
Additional paid in capital519447429402358214
Accumulated deficit(333)(360)(337)(298)(223)(129)
Other undisclosed stockholders' equity attributable to parent     (0)
Total stockholders' equity:186879210413585
TOTAL LIABILITIES AND EQUITY:64430629113616298

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues310297280282 
Revenue, net282 
Cost of revenue
(Cost of Goods and Services Sold)
(130)(194)(166)(3)(0) 
Gross profit:180103115261 
Operating expenses(124)(127)(135)(101)(96)(27)
Other undisclosed operating income    0 
Operating income (loss):56(24)(21)(75)(94)(27)
Nonoperating income (expense)0221(0)(0)
Investment income, nonoperating022   
Other nonoperating income (expense)   1(0)(0)
Interest and debt expense(29)(1)(20) (0)0
Income (loss) from continuing operations before income taxes:28(23)(39)(75)(94)(27)
Income tax expense(1)     
Net income (loss):27(23)(39)(75)(94)(27)
Other undisclosed net income (loss) attributable to parent    0(0)
Net income (loss) available to common stockholders, diluted:27(23)(39)(75)(94)(27)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):27(23)(39)(75)(94)(27)
Comprehensive income (loss), net of tax, attributable to parent:27(23)(39)(75)(94)(27)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: